Promising results in phase 1 trial lead immatics to continue work on vaccine (IMA950) for glioblastoma
immatics biotechnologies GmbH, together with its collaborators Cancer Research UK and Cancer Research Technology today a…
immatics biotechnologies GmbH, together with its collaborators Cancer Research UK and Cancer Research Technology today a…
A theft incident involving the data of 3.3 million people in the US has ended well, with 650 CDs and floppy disks contai…